MedPath

Detection of residual tumor tissue during surgery in ovarian cancer.

Recruiting
Conditions
ovarian cancereierstokkankerovariumkanker
Registration Number
NL-OMON24387
Lead Sponsor
MCG
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1. Female > 21 years old;

2. Ovarian cancer for which debulking surgery is scheduled.

Exclusion Criteria

1. Renal, cardiac or pulmonary failure (ASA III-IV);

2. Present or previous hyperthyreoidism;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intra-operative detection of ovarian cancer by a folate-FITC enhanced optical imaging device, in which visual inspection in combination with routine histology is considered the golden standard for the presence of tumour tissue.
Secondary Outcome Measures
NameTimeMethod
Presence of fluorescent residual disease after intended radical resection by visual observation alone.
© Copyright 2025. All Rights Reserved by MedPath